Release date- 06082019 - A pivotal Phase 3 trial evaluating Dupixent (dupilumab) to treat severe
atopic dermatitis in children aged 6 to 11 years met its primary and secondary endpoints.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi Tuesday jointly announced the extended marketing approval from European Commission (EC) for Dupixent (dupilumab) in the EU to include adolescents 12 to 17 years of age with moderate-to-severe
atopic dermatitis who are candidates for systemic therapy.
Atopic dermatitis is the latest in growing list of chronic inflammatory conditions that have been associated with an increased risk of dementia, according to Dr.
For the treatment of
atopic dermatitis, omalizumab has mostly been used in doses ranging from 300 to 450 mg every 2 to 4 weeks (5-7).
Chiesa Fuxench, M.D., from the University of Pennsylvania Perelman School of Medicine in Philadelphia, and colleagues examined the prevalence of
atopic dermatitis, distribution of disease severity, and impact on health-related quality of life in a cohort of 1,278 U.S.
Results: 84% patients in group A (betamethasone) showed >50% reduction in Scoring of
Atopic Dermatitis (SCORAD) whereas 94% patients in group B (NB-UVB) showed >50% reduction in SCORAD (p=0.554).
According to the researchers, children with
atopic dermatitis (AD) - a type of eczema of the skin - show an increased risk of developing asthma later in life.
This journal supplement is intended for dermatologists, pediatricians, family practitioners, internists, nurses, nurse practitioners, physician assistants, and other clinicians who treat patients with
atopic dermatitis.
Canine
atopic dermatitis (CAD) is a common, recurring, inflammatory and pruritic allergic skin disease in dogs exhibiting characteristic clinical signs associated with IgE antibodies that is most commonly directed against environmental allergens (Halliwell, 2006).
Atopic myelitis is a type of myelitis which has received attention along with the recent dramatic increase in
atopic disease.